Real-World Effectiveness of Palbociclib Plus Letrozole vs Letrozole Alone for Metastatic Breast Cancer With Lung or Liver Metastases: Flatiron Database Analysis.

Front Oncol · 2022 · PMC9291245 · PMID 35860587

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

After adjusting for baseline covariates, the median rwPFS remained longer among those in the palbociclib plus letrozole group versus the letrozole group hazard ratio, 0.70 [95% CI, 0.44–1.10]; P =0.12; Figure 4A ), although the analysis did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.